Takamichi Yamamoto

7PUBLICATIONS
32CO-AUTHORS
Other Asian languages (excl. South-East Asian)PharmacogenomicsPrivacy and data rightsEcosystem services (incl. pollination)Clinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 03, 2026
Long-Term Efficacy of Adjunctive Cenobamate by Focal Seizure Subtypes: Open-Label Extension of a Randomized Clinical Study in a Multinational Asian Population.

|Aug 28, 2026
Long-term efficacy of adjunctive cenobamate: Open-label extension of a randomized, placebo-controlled study in a multinational Asian population.

|Nov 13, 2025
Early response rates with adjunctive cenobamate in uncontrolled focal seizures: Prospective analysis of a randomized, double-blind, placebo-controlled study in a multinational Asian population.

Kensuke Kawai, Eunyeong Choe, Louis Ferrari

|Nov 13, 2025
Clinical factors associated with perampanel retention, response, seizure freedom and tolerability: real-world evidence from the PERMIT Extension study.

Taoufik Alsaadi, Patricia Penovich, Stéphane Auvin

|Oct 27, 2025
A randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of adjunctive cenobamate in Asian patients with focal seizures.

Sang Kun Lee, Peimin Yu, Eunyeong Choe

|Oct 17, 2021
Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal-onset seizures with newly diagnosed or currently untreated recurrent epilepsy: A post hoc analysis of the open-label Study 342 (FREEDOM).

Ryan Edbert Husni, Leock Y Ngo, Hirofumi Senokuchi

Pageof 2

Frequent Collaborators

5 joint publications

Ji Hyun Kim

4 joint publications

William Rosenfeld

4 joint publications

Kensuke Kawai

4 joint publications

Koji Iida